Maximising the commercial benefits of research

Timothy M Dyke
Med J Aust 2014; 201 (11): . || doi: 10.5694/mja14.01551
Published online: 15 December 2014

It is reasonable to expect that the returns from research contribute economically to generate Australia's national wealth, given that Australian Government-funded research, such as through the National Health and Medical Research Council (NHMRC), is supported by public taxes. Australia's national wealth is enhanced through translating research findings into new commercial products, companies or industries. This concept was at the centre of the Wills Review more than 15 years ago, and represents a virtuous cycle of investing in research to create knowledge and translating that knowledge to reap patient and economic benefits that lead to further investment.

  • Research Policy Branch, National Health and Medical Research Council



remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.